On the BSE, 51,000 shares were traded in the counter so far, compared with average daily volumes of 16,000 shares in the past two weeks.

The stock hit 52-week high of Rs 1,212.70 on 3 January 2022. The stock hit a 52-week low of Rs 323.65 on 20 June 2021.

The stock had outperformed the market over the past one month, surging 5.08% compared with 1.12% fall in the Sensex.

The counter had underperformed the market in past one quarter, advancing 1.69% as against Sensex's 2.73% rise.

The scrip had underperformed the market in past one year, declining 53.14% as against Sensex's 6.68% rise.

On the technical front, the stock's daily RSI (relative strength index) stood at 63.050. The RSI oscillates between zero and 100. Traditionally, the RSI is considered overbought when above 70 and oversold when below 30.

On the daily chart, the stock was trading above its 50-day, 100-day and 200-day simple moving average (SMA) placed at 438.62, 431.70 and 473.99 respectively.

Solara Active Pharma Sciences is a public limited company incorporated on February 23, 2017 under the provisions of Companies Act, 2013 with the object of, inter alia, undertaking the business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients.

The company reported net loss of Rs 9.91 crore in Q2 FY23 as compared to net profit of Rs 30.29 crore in Q2 FY22. Net sales declined 15.7% year on year to Rs 338.37 crore in Q2 FY23.